Small Molecule Drug Discovery Market 2019 Prominent Players: Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb, Gilead Sciences, Glaxosmithkline, Johnson & Johnson, Merck & Co., Pfizer

Global Small Molecule Drug Discovery Market is expected to grow at a CAGR of 8.5% during the forecast period. Some of the factors such as rise in drug discovery and development and rising usage of these drugs in the treatment of chronic diseases are driving the market growth. However, high costs of drugs are hindering the market growth.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/19425
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Small molecule drug is a substance that can quickly enter the cells due to its low molecular weight. After entering the cells, it may affect the other molecules like proteins and may cause the cancer cells to die. There are two phases of developing new small molecule drugs. One is Drug discovery, and the other one is Drug development. Small molecule drugs are different from other drugs which have a large molecular weight. So, these targeted therapies are small-molecule drugs or small molecule inhibitors.

Top Industry Players:
Some of the key players profiled in the Small Molecule Drug Discovery Market include Astrazeneca, Boehringer Ingelheim Gmbh, Bristol- Myers Squibb, Gilead Sciences, Inc., Glaxosmithkline, Johnson & Johnson, Merck & Co., Pfizer Inc and Teva Pharmaceuticals.

Browse Report @ https://marketprognosis.com/report/small-molecule-drug-discovery---global-market-outlook-%282017-2026%29/pr-19425
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

By Process Phase, lead optimization segment held significant growth during the forecast period due to increasing strength, selectivity, or pharmacokinetic parameters, rising in cancer and other diseases encouraging investments in lead optimization. Based on geography, North America is anticipated to be one of the leading regions contributing to the global market during the forecast period. There is an increasing number of contract organizations for research and development. This shows that the United States is focusing on R&D activities to meet the rising demands of its people, finally leading the market of North America.
Process Phases Covered:
• Hit Generation and Selection
• Lead Identification
• Lead Optimization
• Target Id/Validation

Therapeutic Areas Covered:
• Anti-Infective
• Cardiovascular
• Central Nervous System
• Dermatology
• Gastrointestinal
• Immunological
• Metabolic
• Oncology
• Orthopedics
• Respiratory
• Other Therapeutic Areas

Enquiry Before Buying @ https://marketprognosis.com/enquiry/19425
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.